索宝蛋白
(603231)
| 流通市值：19.80亿 | | | 总市值：35.67亿 |
| 流通股本：1.06亿 | | | 总股本：1.91亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,240,274,258.89 | 773,865,920.48 | 391,920,304.59 | 1,555,382,604.61 |
| 营业收入 | 1,240,274,258.89 | 773,865,920.48 | 391,920,304.59 | 1,555,382,604.61 |
| 二、营业总成本 | 1,075,039,263.85 | 666,429,394.26 | 340,412,070.35 | 1,435,473,164.94 |
| 营业成本 | 1,018,141,139.7 | 628,831,290.74 | 323,557,282.9 | 1,368,635,123.49 |
| 税金及附加 | 7,011,829.39 | 4,679,314.76 | 1,937,814.31 | 7,327,970.74 |
| 销售费用 | 17,461,119.65 | 11,442,949.61 | 5,352,784.48 | 22,919,109.29 |
| 管理费用 | 31,000,410.69 | 22,168,299.07 | 10,224,417.29 | 38,877,491.6 |
| 研发费用 | 5,469,908.59 | 3,253,258.06 | 1,405,431.57 | 10,410,192.23 |
| 财务费用 | -4,045,144.17 | -3,945,717.98 | -2,065,660.2 | -12,696,722.41 |
| 其中:利息费用 | 76,358.07 | 77,609.38 | 61,431.26 | 140,609.19 |
| 其中:利息收入 | 2,311,455.36 | 1,005,109.95 | 401,664.07 | 6,733,649.72 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 4,014,063.08 | 2,926,444.79 | 1,392,917.74 | 6,201,917.5 |
| 加:投资收益 | 1,581,978.35 | 702,493.6 | 457,457.05 | 5,341,043.26 |
| 资产处置收益 | -499,484.8 | -499,658.78 | -15,384.63 | -29,666.68 |
| 资产减值损失(新) | 16,626.41 | 16,626.41 | - | -4,052,226.63 |
| 信用减值损失(新) | -365,080.09 | -242,456.59 | -589,164.59 | 4,732,646.1 |
| 其他收益 | 7,066,622.65 | 6,506,503.89 | 733,900.98 | 16,194,450.53 |
| 四、营业利润 | 177,049,720.64 | 116,846,479.54 | 53,487,960.79 | 148,297,603.75 |
| 加:营业外收入 | 313,421.09 | 215,708.95 | 176,541.05 | 356,705.75 |
| 减:营业外支出 | 2,724,074.79 | 393,506.69 | 90,732.42 | 4,571,806.81 |
| 五、利润总额 | 174,639,066.94 | 116,668,681.8 | 53,573,769.42 | 144,082,502.69 |
| 减:所得税费用 | 27,951,169.53 | 19,236,287.73 | 9,097,677.01 | 22,901,768.94 |
| 六、净利润 | 146,687,897.41 | 97,432,394.07 | 44,476,092.41 | 121,180,733.75 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 146,687,897.41 | 97,432,394.07 | 44,476,092.41 | 121,180,733.75 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 146,687,897.41 | 97,432,394.07 | 44,476,092.41 | 121,180,733.75 |
| 扣除非经常损益后的净利润 | 141,826,384.5 | 93,203,836.86 | 41,860,638.1 | 109,594,020.11 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.77 | 0.51 | 0.23 | 0.63 |
| (二)稀释每股收益 | 0.77 | 0.51 | 0.23 | 0.63 |
| 八、其他综合收益 | 21,391.58 | 31,626.37 | 3,893.03 | -7,910.06 |
| 归属于母公司股东的其他综合收益 | 21,391.58 | 31,626.37 | 3,893.03 | -7,910.06 |
| 九、综合收益总额 | 146,709,288.99 | 97,464,020.44 | 44,479,985.44 | 121,172,823.69 |
| 归属于母公司股东的综合收益总额 | 146,709,288.99 | 97,464,020.44 | 44,479,985.44 | 121,172,823.69 |
| 公告日期 | 2025-10-31 | 2025-08-28 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |